Table 1.
Studies reporting types of cancer and their standardized incidence ratio after liver transplantation published in the last decade. Only selective data on liver transplant recipients are shown. The marked standardized incidence ratio values (∗) indicate statistical significance at P < 0.05
Authors | Year | Country | Type | Period | n | Overall | Lymphoma | Skin | Head-neck | Renal | Others |
Krynitz et al. [11] | 2013 | Sweden | National Survey | 1970–2008 | 10 476 | 3.4* | 9.6* | 16* | 4.6* | 1.9 | Colon: 2.2; Breast: 1; Prostate: 0.5; Lung: 1.8. |
Chatrath et al. [10] | 2013 | United States | Single centre | 1997–2004 | 534 | 3.1* | 7.1* | – | – | – | – |
Schrem et al. [6] | 2013 | Germany | Single centre | 1983–2010 | 2000 | 1.94* | 10.9* | – | Oral: 1.7; Larynx: 2.3. | 2.6* | Colorectal:1.41*; Breast: 0.83; Vulvar: 23.8*; Prostate: 0.62; Lung: 1.85*. |
Engels et al. [8] | 2011 | United States | National survey | 1987–2008 | 37 888 | – | Non-Hodgkin: 7.77* | – | — | 1.8* | Lung: 1.95*; Liver: 43.8*. |
Baccarani et al. [3] | 2010 | Italy | Two centres | 1991–2005 | 417 | 2.6* | 13.8* | – | 7* | – | Colon: 1.4; Lung: 1.6; Breast: 0.6. |
Jiang et al. [5] | 2008 | Canada | National survey | 1983–1998 | 2034 | 2.5* | Non-Hodgkin: 20.8* | – | 2.5 | 3.1 | Colorectal: 2.6*; Breast: 0.6; Prostate: 1. |
Aberg et al. [2] | 2008 | Finland | National survey | 1982–2005 | 540 | 2.59* | Non-Hodgkin: 13.9*; Hodgkin: 14.7 | 38.5* | Lip: 21.3; Mouth: 14.8. | 4.17 | Colorectal: 1.59; Breast: 0.26; Prostate:1.24; Stomach: 4.97. |
Collet et al. [7] | 2010 | United Kingdom | National survey | 1980–2007 | 6846 | 2.2* | Non-Hodgkin: 13.3*; Hodgkin: 8.9*. | 6.6* | Lip: 20*; Oral: 10*. | 1.8 | Colorectal: 2.3*; Breast: 0.8; Lung: 1.6*. |
Oo et al. [12] | 2005 | United Kingdom | Single centre | 1982–2004 | 1778 | 2.07* | 10.3* | 5.8* | – | – | Colon: 4.9*; Breast: 0.97; Lung: 1.96*. |